Veronica Gruppo

Author PubWeight™ 16.72^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models.	Antimicrob Agents Chemother	2005	3.16
2	Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane.	Nat Chem Biol	2012	2.40
3	Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice.	Antimicrob Agents Chemother	2003	2.30
4	Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitors.	Antimicrob Agents Chemother	2007	1.24
5	Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.	Antimicrob Agents Chemother	2010	1.17
6	The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo.	Mol Microbiol	2004	1.12
7	Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties.	Bioorg Med Chem	2012	1.00
8	Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma.	Immunology	2006	0.95
9	Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.	Antimicrob Agents Chemother	2011	0.95
10	In vivo adaptation of the Wayne model of latent tuberculosis.	Infect Immun	2007	0.92
11	Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugs.	Int J Antimicrob Agents	2005	0.88
12	Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo.	Antimicrob Agents Chemother	2008	0.85